ArticleTransfusion2026
Monitoring and feedback using data in transfusion medicine: A study of practices from the BEST Collaborative.
Article in Transfusion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundIt is imperative that health systems monitor transfusion practice quality and implement improvements when evidence-based practice gaps are identified. Despite the importance of data-driven quality activities, little is known about approaches employed by hospitals. This study aimed to describe strategies used by hospitals to acquire, analyze, and apply transfusion-related quality data. STUDY DESIGN AND
methodsA pre-piloted survey was developed by the core team, and Biomedical Excellence for Safer Transfusion (BEST) Collaborative attendees of meetings were invited to participate. Topics spanned five domains: hospital characteristics, data acquisition, quality metric prioritization, data analysis/visualization, and feedback processes. Responses were summarized to identify patterns and variation across institutions.
resultsNine hospitals of varying size, specialty mix, and transfusion volumes from three continents participated. Most transfusion services acquired transfusion data from both the electronic health record and the laboratory information system (6/9, 67%). Although all sites tracked the number of transfusions, there was wide variation in other metrics prioritized. Transfusion appropriateness was prioritized by 7 of 9 centers, but few reported monitoring antifibrinolytic agent use (2/9, 22%), anemia management (4/9, 44%), and consent (2/9, 22%). All hospitals performed some form of data analysis, but chart/table types and functionalities differed. Feedback was typically provided by transfusion medicine specialists or hematology, but frequency and means differed between sites. DISCUSSION: This descriptive study highlights significant variation in how selected hospitals use data to monitor transfusion practices and provide feedback. There are many opportunities to enhance optimal uses of data to deliver effective quality improvement.
Indexed as
Identifiers
42333648What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.